Ethics grand rounds to focus on fetal therapies
Rapidly advancing biomedical technologies in prenatal diagnosis, fetal surgery and genetics can sometimes provoke public apprehension as well as fascination.
Often, curiosity and confusion go hand in hand when it comes to making sense of the latest developments and debates. Next month, Vanderbilt University Medical Center's Ethics Spring Grand Rounds will take a look at the situation with "Over the Cutting Edge: What are the Moral Boundaries for Experimental Fetal Therapies?"
The address will be presented by Dr. Mark I. Evans, Charlotte B. Failing Professor of Obstetrics and Gynecology, professor and associate director, Center for Molecular Medicine and Genetics and director of the Center for Fetal Diagnosis and Therapy at Wayne State University, Hutzel Hospital.
The Ethics Spring Grand Rounds will be held at noon on Wednesday, April 8, in 208 Light Hall.
Evans is a nationally and internationally recognized expert on genetic and surgical fetal therapies. He has authored and contributed to more than 200 articles and chapters in the areas of intersection between genetics, prenatal diagnosis, fetal and obstetric medicine.
During his talk, Evans will discuss what can be expected from advancements in genetic and surgical fetal therapies.